in the present report methods to deplete brain catecholamine ( ca ) differentially were employed in order to test the hypothesis that central 6-ohda injections act on brain ca substrates per se to produce behavioral and physiological response deficits to angiotensin ii ( ang ii ) challenges .
C0006104
brain
C0004927
behavioral